Compassionate Use of Erwinase [asparaginase] For Pediatric Patients With Acute Lymphoblastic Leukemia Or Non Hodgkins Lymphoma.

Trial Profile

Compassionate Use of Erwinase [asparaginase] For Pediatric Patients With Acute Lymphoblastic Leukemia Or Non Hodgkins Lymphoma.

Completed
Phase of Trial: Phase I

Latest Information Update: 28 Apr 2017

At a glance

  • Drugs Asparaginase (Primary)
  • Indications Acute lymphoblastic leukaemia; Non-Hodgkin's lymphoma
  • Focus Therapeutic Use
  • Acronyms ERWASE
  • Most Recent Events

    • 04 Jan 2012 Actual patient number (87) added as reported by ClinicalTrials.gov.
    • 04 Jan 2012 Actual end date (1 Dec 2011 ) added as reported by ClinicalTrials.gov.
    • 04 Jan 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top